Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on October 1, 2007
Chest, doi:10.1378/chest.07-0389
A more recent version of this article appeared on November 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
chest.07-0389v1
132/5/1532    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaumdally, R. J
Right arrow Articles by Lip, G. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaumdally, R. J
Right arrow Articles by Lip, G. Y.

Platelet activation in coronary artery disease: Intra cardiac versus peripheral venous levels and the effects of angioplasty

Rumi J Jaumdally; Chetan Varma; Andrew D Blann; Robert J MacFadyen and Gregory YH Lip

Haemostasis, Thrombosis and Vascular Biology Unit; University Department of Medicine; City Hospital; Birmingham B18 7QH, England, UK

g.y.h.lip{at}bham.ac.uk

Abstract

BackgroundPlatelet activation and aggregation play a key role in coronary artery disease, with anti-platelet therapies leading to improved clinical outcomes. Limited data exists as to whether peripheral venous blood measurements of platelet physical indices (platelet count, volume and granularity) and soluble markers of platelet activation (eg. P-selectin [sP-sel] and CD 40 ligand [CD40L]) reflect the local (intracardiac) coronary environment. Furthermore, how percutaneous coronary interventions (PCI) affect levels of peripheral/cardiac platelet indices is unclear.

MethodsBlood samples were sequentially acquired from the coronary os, aortic root, coronary sinus and the femoral vein, and where relevant, pre- and post-PCI. Patients undergoing coronary angiography were recruited [n = 87, mean age 59.8 ± 10.8 years; 54 (62%) males], of whom 36 proceeded to PCI. Platelet physical indices and plasma sP-sel and CD40L levels (ELISAs) were measured.

ResultsAt baseline, no intra cardiac vs peripheral differences were noted in sP sel levels, whilst CD40L levels were elevated in the aorta compared to coronary sinus and femoral venous samples. Mean platelet count (MPC) was similar at all 4 sites but within coronary sinus blood, mean volume (MPV) was significantly lower - and mean granularity (MPG) higher - when compared to arterial levels. Though aortic and femoral levels of sP-sel were raised following PCI, trans-cardiac gradients of plasma sP-sel levels were unaffected. PCI was associated with lower CD40L, MPC and MPV levels but a higher granularity of platelets in all sampling sites.

ConclusionsP-sel levels measured peripherally do reflect the cardiac environment, unlike CD40L, MPC, MPV and MPG. PCI leads to further platelet activation (raised sP-sel) despite aggressive anti-platelet therapy use.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American College of Chest Physicians.